NCT00150371
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada